SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-134367
Filing Date
2021-11-04
Accepted
2021-11-04 16:06:51
Documents
3
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2131866d1_def14a.htm DEF 14A 340335
2 GRAPHIC tm2131866d1_def14aimg002.jpg GRAPHIC 262818
3 GRAPHIC tm2131866d1_def14aimg003.jpg GRAPHIC 322948
  Complete submission text file 0001104659-21-134367.txt   1148773
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36641 | Film No.: 211379921
SIC: 2836 Biological Products, (No Diagnostic Substances)